The product-memory moment
Picture a founder and RA/QA lead after a new product event lands: a complaint trend, a peer-device recall, a supplier change, or a customer evidence request. The QMS stores records, but the team still needs to see how the records connect to this product question.
A product-specific compliance digital twin should make that connection visible. It should not decide the answer. It should show sources, records, prior review points, open questions, and owners.
Product Review Workspace checklist
| Workspace layer | What to capture |
|---|---|
| Product question | Complaint, recall signal, supplier issue, software issue, claim review, product-file refresh, customer request, or audit question. |
| Public source ledger | QMSR, eCFR Part 820, MDR context, MAUDE, TPLC, recall or early-alert source, access date, and source limit. |
| Internal records | Complaint, CAPA, risk, PMS, supplier, service, design, label, IFU, training, support, and prior review records. |
| Review points | Same/different facts, repeated mechanism candidates, evidence gaps, owner questions, and next action candidates. |
| Decision boundary | Which regulatory, quality, risk, clinical, legal, customer, supplier, operations, and leadership decisions remain open. |
What good looks like
A useful workspace gives a reviewer one pane of product memory: source, record, review point, owner, status, and limitation. It avoids the common failure where a new event is reviewed as if prior context did not exist.
The workspace should also protect boundaries. It can prepare evidence and questions, but qualified reviewers own the conclusions.
Source ledger
What it can tell you
FDA's current QMSR context and inspection transition information for medical-device quality systems.
What it cannot decide
Whether one product review workspace, evidence map, or QMS record set satisfies a reviewer.
What it can tell you
Current Part 820 source context for finished-device quality-system requirements.
What it cannot decide
How one company's QMS records, complaint process, CAPA process, or product memory should be judged.
What it can tell you
FDA public context for MDR reporting and medical-device problem reporting sources.
What it cannot decide
Whether one product event, complaint, or malfunction triggers a company action.
What it can tell you
Public medical-device report search context that can support external signal collection.
What it cannot decide
Whether one MAUDE report applies to a product, proves causation, or changes a company decision.
What it can tell you
How FDA frames TPLC source integration and limitations for premarket and postmarket data sources.
What it cannot decide
Whether an integrated public signal is complete or decisive for one product.
What it can tell you
Public recall and early-alert signals that may create product-review questions.
What it cannot decide
Whether one company product, complaint, CAPA, or customer communication should change.
Frequently asked questions
Is a compliance digital twin an official regulatory artifact?
No. Here it is an operating model for a product-specific review workspace. The official record, quality-system decisions, regulatory positions, clinical positions, and legal conclusions remain with qualified owners.
What makes the workspace useful for RA/QA?
It connects public signals, QMS records, complaint history, CAPA, risk, PMS, supplier files, and prior decisions to one product question without turning the evidence map into an unreviewed conclusion.
Need a product-specific review workspace?
Send one product question and the record families involved. We can scope a source-backed Product Review Workspace packet for qualified review.
Reader feedback
Useful pages should feed the next topic choices. Leave a signal or a short comment.